{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:39:13Z","timestamp":1649205553292},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12253-017-0369-1","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T21:04:58Z","timestamp":1513458298000},"page":"889-895","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic and Immunohistochemical Study of Combined Small Cell Carcinoma and Urothelial Carcinoma Molecular Subtype"],"prefix":"10.1007","volume":"25","author":[{"given":"Guang-Qian","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela D.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,16]]},"reference":[{"issue":"1","key":"369_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrurol.2010.208","volume":"8","author":"J Falke","year":"2011","unstructured":"Falke J, Witjes JA (2011) Contemporary management of low-risk bladder cancer. Nat Rev Urol 8(1):42\u201349","journal-title":"Nat Rev Urol"},{"issue":"1","key":"369_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD (2015) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 15(1):25\u201341.5","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"369_CR3","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1158\/1078-0432.CCR-10-2770","volume":"17","author":"JB Shah","year":"2011","unstructured":"Shah JB, McConkey DJ, Dinney CP (2011) New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Clin Cancer Res 17(9):2608\u20132612","journal-title":"Clin Cancer Res"},{"issue":"2","key":"369_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25(2):152\u2013165","journal-title":"Cancer Cell"},{"issue":"19","key":"369_CR5","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869\u201310874","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"369_CR6","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1073\/pnas.1120605109","volume":"109","author":"JP Volkmer","year":"2012","unstructured":"Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB et al (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A 109(6):2078\u20132083","journal-title":"Proc Natl Acad Sci U S A"},{"key":"369_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.lungcan.2011.08.004","volume":"75","author":"SP Riaz","year":"2012","unstructured":"Riaz SP, Luchtenborg M, Coupland VH, Spicer J, Peake MD, Moller H (2012) Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75:280\u2013284","journal-title":"Lung Cancer"},{"key":"369_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cncr.20456","volume":"101","author":"L Cheng","year":"2004","unstructured":"Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM et al (2004) Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957\u2013962","journal-title":"Cancer"},{"issue":"2","key":"369_CR9","first-page":"217","volume":"25","author":"M Pant-Purohit","year":"2010","unstructured":"Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L (2010) Small cell carcinoma of the urinary bladder. Histol Histopathol 25(2):217\u2013221","journal-title":"Histol Histopathol"},{"issue":"11","key":"369_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.5858\/arpa.2011-0267-RS","volume":"136","author":"X Zhao","year":"2012","unstructured":"Zhao X, Flynn EA (2012) Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Arch Pathol Lab Med 136(11):1451\u20131459","journal-title":"Arch Pathol Lab Med"},{"key":"369_CR11","unstructured":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (2015) 4th edition. In: Travis, W.D., Brambilla, E., Burke, A.P., Marx, A., Nicholson, A. G. eds. WHO Classification of Tumours; IARC press"},{"key":"369_CR12","unstructured":"WHO Classification of Tumours of the Urinary System and Male Genital Organs (2016) 4th edition. In: Moch, H, Humphrey, PA, Ulbright, TM, Reuter, VE, eds. WHO Classification of Tumours; IARC press"},{"key":"369_CR13","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010; p569\u2013p578"},{"key":"369_CR14","unstructured":"ASCO\u2013CAP HER2 Test Guideline Recommendations, CAP (2013). \n                    http:\/\/www.cap.org\/apps\/docs\/committees\/immunohistochemistry\/summary of recommendations.pdf"},{"key":"369_CR15","first-page":"1179","volume":"6","author":"CP Hou","year":"2013","unstructured":"Hou CP, Lin YH, Chen CL, Chang PL, Tsui KH (2013) Clinical outcome of primary small cell carcinoma of the urinary bladder. Onco Targets Ther 6:1179\u20131185","journal-title":"Onco Targets Ther"},{"issue":"suppl. 2","key":"369_CR16","first-page":"256A","volume":"29","author":"D Pradhan","year":"2016","unstructured":"Pradhan D, Green A, Fuhrer KA, Bastacky SI, Dhir R, Parwani A, Roy S (2016) Utility of immunohistochemistry for distinguishing luminal and basal subtypes of urothelial carcinoma on formalin fixed paraffin embedded tissue. Mod Pathol 29(suppl. 2):256A","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"369_CR17","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/modpathol.2011.150","volume":"25","author":"WD Travis","year":"2012","unstructured":"Travis WD (2012) Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 25(Suppl 1):S18\u2013S30","journal-title":"Mod Pathol"},{"key":"369_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00918679","volume":"11","author":"HM Shepard","year":"1991","unstructured":"Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I et al (1991) Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. J Clin Immunol 11:117\u2013127","journal-title":"J Clin Immunol"},{"key":"369_CR19","unstructured":"Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990;50:5184\u20135187"},{"key":"369_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3816\/CCC.2004.n.025","volume":"4","author":"AM Ochs","year":"2004","unstructured":"Ochs AM, Wong L, Kakani V, Neerukonda S, Gorske J, Rao A, Riggs M, Ward H, Keville L (2004) Expression of vascular endothelial growth factor and HER2\/neu in stage II colon cancer and correlation with survival. Clin Colorectal Cancer 4:262\u2013267","journal-title":"Clin Colorectal Cancer"},{"key":"369_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A et al (2010) Trial investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697","journal-title":"Lancet"},{"key":"369_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00428-013-1425-1","volume":"462","author":"G MJ","year":"2013","unstructured":"MJ G, Hong SM, Jung SJ (2013) HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas. Virchows Arch 462:603\u2013607","journal-title":"Virchows Arch"},{"key":"369_CR23","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00432-010-0850-7","volume":"136","author":"A Marin","year":"2010","unstructured":"Marin A, Arranz E, Sanchez A, Aunon P, Baron M (2010) Role of anti-her-2 therapy in bladder carcinoma. J Cancer Res Clin Oncol 136:1915\u20131920","journal-title":"J Cancer Res Clin Oncol"},{"key":"369_CR24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/annonc\/mdp488","volume":"21","author":"M La\u00e9","year":"2010","unstructured":"La\u00e9 M, Couturier J, Oudard S, Radvanyi F, Beuzeboc P, Vieillefond A (2010) Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Ann Oncol 21:815\u2013819","journal-title":"Ann Oncol"},{"key":"369_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.urology.2003.10.040","volume":"63","author":"CL Coogan","year":"2004","unstructured":"Coogan CL, Estrada CR, Kapur S, Bloom KJ (2004) HER-2\/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder. Urology 63:786\u2013790","journal-title":"Urology"},{"issue":"8","key":"369_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/modpathol.2011.69","volume":"24","author":"CB Ching","year":"2011","unstructured":"Ching CB, Amin MB, Tubbs RR et al (2011) HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol 24(8):1111\u20131119","journal-title":"Mod Pathol"},{"issue":"2","key":"369_CR27","first-page":"699","volume":"7","author":"Y Sasaki","year":"2014","unstructured":"Sasaki Y, Sasaki T, Kawai T et al (2014) HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients. Intl J Clin Exp Pathol 7(2):699\u2013708","journal-title":"Intl J Clin Exp Pathol"},{"issue":"3","key":"369_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00428-004-1041-1","volume":"445","author":"P Soriano","year":"2004","unstructured":"Soriano P, Navarro S, Gil M, Llombart-Bosch A (2004) Small-cell carcinoma of the urinary bladder: a clinico-pathological study of ten cases. Virchows Arch 445(3):292\u2013297","journal-title":"Virchows Arch"},{"issue":"3B","key":"369_CR29","first-page":"2001","volume":"25","author":"X Wang","year":"2005","unstructured":"Wang X, Jones TD, Maclennan GT et al (2005) P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25(3B):2001\u20132004","journal-title":"Anticancer Res"},{"issue":"2","key":"369_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.ju.0000132413.85866.fc","volume":"172","author":"AO Siefker-Radtke","year":"2004","unstructured":"Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB et al (2004) Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol 172(2):481\u2013484","journal-title":"J Urol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-017-0369-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T05:34:03Z","timestamp":1567748043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-017-0369-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,16]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s12253-017-0369-1","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,16]]},"assertion":[{"value":"16 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}